These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36106749)

  • 1. Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer.
    Moik F; Ay C
    J Thromb Haemost; 2022 Dec; 20(12):2733-2745. PubMed ID: 36106749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic system activation in breast cancer: Searching for new biomarkers for cancer risk prediction and outcomes.
    Marchetti M; Russo L; Giaccherini C; Gamba S; Falanga A
    Thromb Res; 2022 May; 213 Suppl 1():S46-S50. PubMed ID: 36210561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic biomarkers in occult cancer and cancer risk prediction.
    Marchetti M; Falanga A
    Thromb Res; 2020 Jul; 191 Suppl 1():S37-S42. PubMed ID: 32736777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic Biomarkers and Cancer Prognosis: Where Do We Stand?
    Falanga A; Marchetti M; Russo L
    Semin Thromb Hemost; 2021 Nov; 47(8):962-971. PubMed ID: 34450680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic biomarkers in cancer progression.
    Falanga A; Marchetti M
    Thromb Res; 2018 Apr; 164 Suppl 1():S54-S61. PubMed ID: 29703485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer.
    Moik F; Posch F; Grilz E; Scheithauer W; Pabinger I; Prager G; Ay C
    Thromb Res; 2020 Mar; 187():9-17. PubMed ID: 31945589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale identification of functional microRNA targeting reveals cooperative regulation of the hemostatic system.
    Nourse J; Braun J; Lackner K; Hüttelmaier S; Danckwardt S
    J Thromb Haemost; 2018 Nov; 16(11):2233-2245. PubMed ID: 30207063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary approach to the challenge of hemostasis.
    Levy JH; Dutton RP; Hemphill JC; Shander A; Cooper D; Paidas MJ; Kessler CM; Holcomb JB; Lawson JH;
    Anesth Analg; 2010 Feb; 110(2):354-64. PubMed ID: 20007735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premorbid Hemostasis in Women with a History of Pregnancy Loss.
    Peshkova AD; Safiullina SI; Evtugina NG; Baras YS; Ataullakhanov FI; Weisel JW; Litvinov RI
    Thromb Haemost; 2019 Dec; 119(12):1994-2004. PubMed ID: 31587245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Hemostatic Biomaterials for Sealing Wounds.
    Montazerian H; Davoodi E; Baidya A; Baghdasarian S; Sarikhani E; Meyer CE; Haghniaz R; Badv M; Annabi N; Khademhosseini A; Weiss PS
    Chem Rev; 2022 Aug; 122(15):12864-12903. PubMed ID: 35731958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Utility of the Markers of Coagulation and Hemostatic Activation Profile in the Management of Embolic Strokes of Undetermined Source.
    Liu M; Ellis D; Duncan A; Belagaje S; Belair T; Henriquez L; Rangaraju S; Nahab F
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105592. PubMed ID: 33454647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
    Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
    J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the hemostatic system during cardiopulmonary bypass.
    Sniecinski RM; Chandler WL
    Anesth Analg; 2011 Dec; 113(6):1319-33. PubMed ID: 22003219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
    Ay C; Pabinger I
    Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic imbalance in active and quiescent ulcerative colitis.
    van Bodegraven AA; Schoorl M; Baak JP; Linskens RK; Bartels PC; Tuynman HA
    Am J Gastroenterol; 2001 Feb; 96(2):487-93. PubMed ID: 11232695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings.
    Schreiber MA; Neveleff DJ
    AORN J; 2011 Nov; 94(5):S1-20. PubMed ID: 22035823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of eprosartan on the hemostatic system in patients with chronic kidney disease associated with hereditary thrombophilia].
    Kaliuzhin VV; Sibireva OF; Urazova OI; Tkalich LM; Zibnitskaia LI; Kaliuzhina EV; Sazonov ÉA; Grankina VIu
    Ter Arkh; 2013; 85(9):77-81. PubMed ID: 24261234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of pyroptosis in hemostasis activation in sepsis.
    Zhu C; Liang Y; Luo Y; Ma X
    Front Immunol; 2023; 14():1114917. PubMed ID: 36756123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.